BE-SAFE shares international lessons through Choosing Wisely Canada
On the 28th of January 2026, BE-SAFE featured in a dedicated Choosing Wisely Canada webinar, bringing together research insights and practical perspectives on safer benzodiazepine deprescribing.
The session, BE-SAFE: International Lessons on Safe Benzodiazepine Deprescribing, featured Anne Spinewine, Maria López Toribio and Jeremy Grimshaw. It explored how the Choosing Wisely De-Implementation Framework is being applied within BE-SAFE to support changes in practice and reduce the use of potentially harmful sleeping medicines among older adults.
Speakers shared insights from developing and testing practical approaches, discussed common barriers to deprescribing, and reflected on lessons across participating countries. The exchange highlighted the importance of connecting evidence with the realities of healthcare delivery to support safer, patient-centred care.
Missed the webinar? The recording is available online!
📺 Visit the event page to watch the recording
BE-SAFE in a nutshell
The BE-SAFE project is targeting patient safety by addressing knowledge and practice gaps related to the reduction of medications used for sleep problems in Europe. Experts and patients are involved to promote an interdisciplinary and inter-sectorial approach. BE-SAFE is a European research project funded by the European Commission Horizon programme under the work programme HORIZON-HLTH-2021-CARE-05-01: Enhancing quality of care and patient safety) and by the Swiss State Secretariat for Education, Research and Innovation (SERI) (contract No 22.00116). The project duration will be from 2022 to 2027.
|
Press contact |
|
|
Prof. Anne Spinewine |
Laura Fernández Maldonado |
|
Project coordinator |
Communication Coordinator |
